Amicus Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020
July 28 2020 - 7:00AM
Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company
will host a conference call and live audio webcast on Monday,
August 10, 2020 at 8:30 a.m. ET to discuss financial results for
the second quarter ended June 30, 2020.
The call will be led by John F. Crowley, Chairman and Chief
Executive Officer. He will be joined on the call by additional
members of the Amicus senior leadership team. Interested
participants and investors may access the conference call by
dialing 877-303-5859 (U.S./Canada) or 678-224-7784 (international),
conference ID: 4949075.
A live audio webcast and related presentation materials can also
be accessed via the Investors section of the Amicus Therapeutics
corporate website at ir.amicusrx.com. Web participants are
encouraged to register on the website 15 minutes prior to the start
of the call.
A replay of the call will be available for seven days beginning
at 11:30 a.m. ET. Access numbers for this replay are 855-859-2056
(U.S./Canada) and 404-537-3406 (international); conference ID:
4949075.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
metabolic diseases. With extraordinary patient focus, Amicus
Therapeutics is committed to advancing and expanding a robust
pipeline of cutting-edge, first- or best-in-class medicines for
rare metabolic diseases. For more information please visit the
company’s website at www.amicusrx.com, and follow on Twitter and
LinkedIn.
CONTACT:
Amicus TherapeuticsAndrew FaughnanDirector,
Investor Relationsafaughnan@amicusrx.com (609) 662-3809
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Sep 2023 to Sep 2024